Diagnostics. Together.
Our mission is to offer a better life with advanced diagnostics.
Cancer diagnostics
Uniogen’s unique glycovariant immunoassay technology is based on nanoparticles coated with carbohydrate group-specific binders at a high density, translating to an improved sensitivity and specificity compared to conventional assays. We’re currently developing our first proprietary test for the early detection of ovarian cancer and hold patents for detection of a variety of cancer types.
Instruments
Uniogen is a state-of-the-art manufacturer of individualized, low-maintenance modular microplate readers with built-in dispensers, small footprint, and flexible software for versatile assay types and plate formats. Available measuring technologies include upconverting nanoparticles (Upcon™), time-resolved fluorometry (TRF), fluorescence, luminescence, and absorbance.
Upcon™ labeling technology
Upcon™ is a first-of-a-kind labeling technology utilizing photostable upconverting nanoparticles that allow measurement without photobleaching, self-quenching or autofluorescence, and bright luminescence with discrete emission bands —even through tissue and in whole blood. Upcon is applicable to quantitative lateral flow tests, bioaffinity assays, microscopy, and imaging.
Reagents and services
Uniogen is a specialist provider of ready-to-use reagents, components, and individualized assay development services for high-quality IVD immunoassays and antibody tests. Our wide array of available custom assay services includes kit manufacturing, plate production, biomolecule conjugation, and buffer preparation—all adaptable for your specific needs.
Rapid GenomEra® PCR tests
GenomEra® CDX system by Uniogen is a powerful tool for running molecular diagnostics routinely and cost-efficiently—with zero compromises in assay reliability or quality. Our current offering of CE-marked GenomEra IVD tests covers ten different assay kits for the detection of different infectious agents, including SARS-CoV-2.
News & events
